Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000222591 | SCV000230517 | likely benign | not specified | 2016-03-23 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000222591 | SCV000271669 | uncertain significance | not specified | 2015-09-10 | criteria provided, single submitter | clinical testing | The p.Ala1901Thr variant in DMD has not been previously reported in individuals with cardiomyopathy, but has been identified in 14/47910 European chromosomes (i ncluding 6 hemizygotes) by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; rs201302282). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Ala1901Thr variant is uncertain. |
Gene |
RCV001719984 | SCV000532232 | benign | not provided | 2020-09-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000459519 | SCV000560857 | benign | Duchenne muscular dystrophy | 2024-01-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000222591 | SCV000603368 | uncertain significance | not specified | 2017-03-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617904 | SCV000735569 | likely benign | Cardiovascular phenotype | 2019-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetics and Genomics Program, |
RCV000157167 | SCV001434172 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Blueprint Genetics | RCV000157167 | SCV000206891 | uncertain significance | Primary dilated cardiomyopathy | 2014-09-29 | no assertion criteria provided | clinical testing |